Global Dental Lab Market is expected to grow with the CAGR of 12.4% in the forecast period of 2022 to 2029. The years considered for study are as mentioned below.

Access Full Report at https://databridgemarketresearch.com/reports/global-dental-lab-market

Global dental lab market is a highly consolidated market, which includes specific number of key players. The market has witnessed increased strategic developments owing to favourable market scenario.

The major players dealing in global dental lab market are introducing strong range of products provider along with launching new products and adopting strategic initiative such as acquisition, agreement into the market. This helped companies to maximize the sales with enhanced product portfolio.

For instance

• In June 2022, Henry Schein, Inc, acquired Condor Dental which has strengthen the company’s distribution business segment in Switzerland. This acquisition has enhanced the company’s revenue and boosted the supply and distribution capabilities of the dental instruments across the dentists.

Henry Schein, Inc. is the dominating player in global dental lab market. The other key players existing in the market includes 3M, Ultradent Products Inc., BioHorizons IPH, Inc., Young Innovations, Inc., A-dec Inc., Carestream Health, Dentatus, 3Shape A/S, Dentsply Sirona, Septodont, VOCO Gmbh, Roland DG Corporation, Formlabs, PLANMECA OY, OSSTEM U.K., Henry Schein, Inc., GC Corporation, Envista (A subsidiary of Danaher Corporation), Kulzer Gmbh (A subsidiary of Mitsui Chemicals, Inc), BIOLASE, Inc., BEGO GmbH & Co. KG, Bicon, LLC, ZimVie Inc. (A subsidiary of Zimmet Biomet Holdings), Pindan Dental Laboratory, CAMLOG Biotechnologies GmbH, Institut Straumann AG among others.

 Henry Schein, Inc.

Henry Schein, Inc. headquartered in New York, the U.S. was founded in the year 1932. The company is engaged in providing solutions that support dental laboratories, government and institutional health care clinics, as well as other alternate care sites. The company has two business segments including dental and medical among which dental is the market focused segment. The company is providing products via dental and medical product categories among these dental is the market focused category. The company is engaged in acquisition, partnerships and agreements among other strategic initiatives in dental lab.

For instance,

• In June, 2016, Henry Schein, Inc acquired Custom Automated Prosthetics (CAP) which is a Custom Automated Prosthetics (CAP), a digital laboratory company engaged in serving U.S. dental labs. This company acquisition has boosted the company’s existing dental product portfolio and allowed it to generate more revenue in existing market.

The company has wide presence across North America, Europe, Asia-Pacific, Middle East and Africa. The company has various subsidiaries including Henry Schein Medical Systems, Inc. (U.S.), Henry Schein One, LLC (U.S.), Orange Acquisition Corp (U.S.), Provet Holdings Limited (Australia), BioHorizon (U.S.) and others.

Dentsply Sirona

Dentsply Sirona was founded in 1899. The company is engaged in the manufacturing of professional dental solutions. The company is providing products via two business segments including technologies & equipment, consumables among which technologies & equipment is market focused category. The company is providing products via several product categories including Digital Impression, CEREC, Dental Labs, Endodontics, Instruments, Orthodontics, Impalantology, Hygiene System, Imaging System, Treatment Centers, Restorative. The market focus products lie under Dental Labs, Endodontics, Instruments, Implantology, Hygiene System, Imaging System, Restorative, Orthodontics product categories. The company is engaged in product launch, partnerships and agreements among other strategic initiatives in dental lab.

For instance,

• In September 2021, Dentsply Sirona launched the implantology product portfolio that is the DS implants DS primer taper implants. The launch of this product has enhanced the company’s existing dental product portfolio. Moreover helped the company to penetrate its root in global dental market.

The company has wide presence across North America, Europe, Asia-Pacific, Middle East and Africa. The company has various subsidiary companies including Friadent GmbH (Germany), DeguDent (Germany), Dentsply France SAS (France) and others.

Envista (A subsidiary of Danaher Corporation)

Envista (A subsidiary of Danaher Corporation) headquartered in California, the U.S. The company focuses to deliver the best possible patient care through industry-leading products, solutions, and technology. Our comprehensive portfolio, including dental implants. The company is operating its business through two business segments including Equipment and Consumables, Specialty Products & Technologies and both the segments are market focused business segments. The company is engaged in providing products via two product categories including Equipment and Consumables, Specialty Products & Technologies and both of which are the market focused category. The company is engaged in product acquisition, partnerships and agreements among other strategic initiatives in dental lab.

For instance,

• In February 2022, Envista (a subsidiary of Danaher Corporation) went under partnership with Vitaldent Group. This partnership positioned Envista as one of the preferred supplier of dental implants and clear aligners. This partnership boosted the company’s revenue in the market.

The company has wide presence across North America, Europe, Asia-Pacific, Middle East and Africa. The company has various subsidiaries companies including Nobel Biocare (Switzerland), DEXIS LLC (the U.S.), KaVo Kerr (the U.S.), Metrex Research Corp (the U.S.), KaVo Dental (the U.S.) among others.